Day: ខែ​កញ្ញា 4, 2025

TOKYO, Japan, September 4, 2025 – (JCN Newswire via SeaPRwire.com) — NEC Corporation (NEC; TSE: 6701) today announced that it will begin a proof of concept (PoC) for introducing an Earthquake Early Warning System (EEWS) in Colombia. This follows NEC’s selection to undertake the “Project for Conducting a Feasibility Study on the Introduction of ICT-Based Early Earthquake Detection and Analysis Technology in the Republic of Colombia,” for which Japan’s Ministry of Internal Affairs and Communications had issued a public solicitation for proposals.With the ultimate goal of providing an EEWS overseas for the first time, NEC plans to conduct this PoC in Colombia between September 2025 and March 2026 to verify the effectiveness of the EEWS and identify any potential issues.The role of EEWS in earthquake early warningsBackgroundColombia is a seismically active nation located along the circum-Pacific Ring of Fire. Extensive human and material damage were reported following a magnitude 6.2 earthq…

TOKYO, September 4, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the company will deliver a total of 11 presentations, including clinical data on the selective orexin 2 receptor agonist (OX2R)E2086 and the latest findings on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO®) at the World Sleep Congress (World Sleep 2025) to be held in Singapore from September 5 to 10.Key presentations include results from the Phase Ib clinical study exploring the efficacy (Proof of Mechanism) of E2086 in people diagnosed with narcolepsy type 1 (NT1) and the Phase IV clinical study(SELENADE Study) investigating the effect of lemborexant in people whose insomnia was comorbid with depressive episodes of major depressive disorder and bipolar disorder (Poster 3-133). The company will also host a symposium introducing the latest evidence on lemborexant in Asia.Eisai considers neurology, including s…